Write For Us

Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet

Sponsored Post Vitamin D2 Canada Persia
72 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a long-awaited analysis published in The Lancet. The study also found it to be 65.2 per cent effective against the more dangerous Delta variant of the coronavirus in its preliminary analysis but said further investigations are necessary to confirm it.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Koo: https://www.kooapp.com/profile/ndtv
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#BreakingNews #LatestNews #TodayNews #PoliticalNews #News
Category
Asia
Tags
NDTV 24x7, tv teaser, bulletin
Sign in or sign up to post comments.
Be the first to comment